MARKET

BETRF

BETRF

Betterlife Pharma Inc
OTCMQB
0.052
NaN%
Closed 09:30 04/15 EDT
OPEN
--
PREV CLOSE
0.052
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.088
52 WEEK LOW
0.028
MARKET CAP
8.01M
P/E (TTM)
-5.4737
1D
5D
1M
3M
1Y
5Y
1D
BetterLife Pharma extends maturity of 2024 convertible debentures by one year
PUBT · 2d ago
Weekly Report: what happened at BETRF last week (0406-0410)?
Weekly Report · 2d ago
BetterLife Pharma Issues Shares and Extends Convertible Debenture Maturities
TipRanks · 5d ago
BetterLife Pharma targets up to $500,000 in C$ 0.07 private placement units
Reuters · 6d ago
BetterLife Pharma Launches $500,000 Private Placement to Advance LSD-Derived Neurology Drug
TipRanks · 04/08 22:19
Weekly Report: what happened at BETRF last week (0330-0403)?
Weekly Report · 04/06 10:40
BetterLife Pharma converts $215,320 debentures into 2.15 million shares, warrants
Reuters · 04/03 13:37
Weekly Report: what happened at BETRF last week (0323-0327)?
Weekly Report · 03/30 10:40
More
About BETRF
BetterLife Pharma Inc. is a biotechnology company. The Company is primarily focused on developing and commercializing two compounds, BETR-001 and BETR-002, to treat neuro-psychiatric and neurological disorders. BETR-001, which is in preclinical, is a non-hallucinogenic second-generation lysergic acid diethylamide (LSD) derivative molecule that mimics the projected therapeutic potential of LSD in the treatment of disorders, such as depressive disorder, anxiety disorder and neuropathic pain and other neuro-psychiatric and neurological disorders. BETR-002, which is in preclinical, is a formulation of a derivative of dihydrohonokiol, a known anti-anxiety compound, with the potential for treatment of anxiety related disorders, including benzodiazepine dependency. It is also refining and developing drug candidates from a set of complementary interferon-based technologies, which have the potential to engage the immune system to fight viral infections.

Webull offers BetterLife Pharma Inc stock information, including OTCMQB: BETRF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BETRF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BETRF stock methods without spending real money on the virtual paper trading platform.